73 / 510
Cuidados
Continuos
72
BIBLIOGRAFÍA
Rebecca Siegel, DeepaNaishadham, Ahmedin Jemal. Cancer Statistics 2012. CA Cancer J Clin 2012;
(62): 10-29.
Bakitas M, Lyons KD, Hegel MT, Balan S, Brokaw FC, Seville J et al. Effects of a palliative care
intervention on clinical outcomes in patients with advanced cancer: The Project ENABLE II
randomized controlled trial. JAMA 2009; 302(7):741–74.
Temel JS, Greer JA, Muzikansky A, Gallagher ER, Admane S, Jackson VA et al. Early palliative care
for patients with metastatic non-small cell lung cancer. N Engl J Med 2010; 363(8):733–742.
Johnsen AT, Damkier A, Vejlgaard TB, Lindschou J, Sjøgren P, Gluud P et al. A randomised,
multicentre clinical trial of specialised palliative care plus standard treatment versus standard
treatment alone for cancer patients with palliative care needs: the Danish palliative care trial
(DanPaCT) protocol. BMC Palliative Care 2013; (12):37: 4-6.
Cassidy J, Bissett D, Spence RAJ, Payne M. Oxford Handbook of Oncology. 3º Ed. New York:
Oxford University Press; 2010.
Miner TJ, Jaques DP, Tavaf-Motamen H, Shiver CD. Decision making on surgical palliation based on
patient outcome data. Am J Surg. 1999; 177 (2): 150-154.
Krouse RS, Nelson RA, Farrell BR, Baiba Grube, Gloria Suárez, Wagman LD et al. Surgical
Palliation at a Cancer Center. Incidence and Outcomes. Arch Surg 2001; 136(7): 773-778.
Paula Cifuentes Henderson, Dowling P, Rikio Ozaki. Palliative surgery for cancer pain. West J Med.
2002; 176(2): 110-114.
Jarosław Łyczek, Damian Kazalski, Łukasz Kowalik, Marcin Sawicki. Comparison of the GTV
coverage by PTV and isodose of 90% in 2D and 3D planning during
endobronchial brachytherapy in the palliative treatment of patients with advanced lung cancer. Pilot
study. Brachytherapy 2012; 4(2): 113-115
GomezBernal A. Tratamiento sistémico del cáncer. Quimioterapia. En: CruzHernández JJ. Oncología
Clínica. 5ª Ed. Madrid: Aula Médica; 2012. p.153-169
Burris HA 3rd, Moore MJ, Andersen J, Green MR, Rothenberg ML, Modiano MR et al.
Improvements in survival and clinical benefit with gemcitabine as first line therapy for patients with
advanced pancreas cancer: a randomized trial. J Clin Oncol 1997; 15(6): 2403-2413.
Lo Sing-hung. Homonal therapy and targeted therapy in palliative cancer care. HKSPM Newsletter
2007:14-17.
K Oberg, P Hellman, P Ferolla, M Papotti. Neuroendocrine gastro-entero-pancreatic tumors: ESMO
Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann of Oncol 2012; 23(7): 124- 130.
Gomez-Roca C, Delord JP. Emerging new anticancer therapies in 2013.Curr Opin Oncol 2014; 26(3):
357-362.
American Society of Clinical Oncology. Previsional clinical opinion: the integration of palliative care
into standard oncology care. J Clin Oncol 2012; 30(8): 880-887
1.
2.
3.
4.
5.
6.
7.
8.
9
10.
11.
12.
13.
14.
15.